Contoso

Pharmaceuticals

Presentation Cover
MIGRATION Option 1
Lorem ipsum dolor sit amet,
consectetur
By: Mariam Khaliladipiscing elit.
Jannat Moh’d
The movement of people
 

from one place to

another with the
intentions of settling,
permanently or
temporarily at a new
location. The movement
is often over long
distances and from one
country to another, but WHAT IS
internal migration is
also possible; indeed, MIGRATION ?
this is the dominant Contoso
form globally. Pharmaceuticals
Migration can be
permanent,
temporary,
voluntary or WHAT ARE THE
forced. It can be MAIN TYPES OF
international or MIGRATION ?
internal.
Contoso
Pharmaceuticals
 PUSH FACTORS
PULL FACTORS
Cultural Environmental Economic
• Political • Diseases • Less money
instability
• Environmental • To gain
• Safety protection money

Contoso
Pharmaceuticals
THANK
Thank You
YOU April Hansson

+1 23 987 6554
april@contoso.com
Contoso
www.contoso.com Pharmaceuticals
QUESTIONS
TIME
Contoso
Pharmaceuticals
The Problem

Declining Market Financial Trust Cost Margins

Lorem ipsum dolor sit Etiam aliquet eu mi Integer convallis Suspendisse sit amet Ut congue quis tortor
amet, consectetur quis lacinia. Ut suscipit ante eu ipsum varius finibus varius eget sodales.
adipiscing elit. fermentum a magna varius. Morbi a purus justo viverra blandit.
ut eleifend. dolor.

Contoso
Pharmaceuticals

page 7
 Unique First to Market
Lorem ipsum dolor sit Etiam aliquet eu mi.
amet, consectetur Ut fermentum a
adipiscing elit. magna ut eleifend.

Product
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
Tested Authentic Etiam aliquet eu mi quis.
Integer convallis Suspendisse sit amet
suscipit eu varius.
Morbi a purus dolor.
ipsum varius finibus
justo viverra blandit.
Contoso
Pharmaceuticals

page 8
Emphasize your
main benefit
Other benefits include
• Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
• Nunc tempus, risus sodales hendrerit,
arcu dolor commodo libero. Contoso
Pharmaceuticals

page 9
Business Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Research Finance Invest

Lorem ipsum dolor sit Etiam aliquet eu mi Integer convallis
amet, consectetur quis lacinia. Ut suscipit ante eu
adipiscing elit. fermentum a magna varius. Morbi a purus
ut eleifend. dolor.

Contoso
Pharmaceuticals

page 10
Market Opportunity Option 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit.

$1B
• Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
• Etiam aliquet eu mi quis
lacinia. Ut fermentum a
magna ut eleifend. Integer
convallis suscipit ante eu
varius.
• Morbi a purus dolor.
Suspendisse sit amet ipsum
finibus justo viverra blandit.
$2B
• Ut congue quis tortor eget
sodales. Nulla a erat eget
nunc hendrerit ultrices eu nec
nulla.
• Donec viverra leo aliquet,
auctor quam id, convallis orci.
Contoso
Pharmaceuticals

page 11
Market Opportunity Option 2
Integer convallis suscipit ante eu varius. Morbi a purus dolor.

$3B
Opportunity to Build
$2B
Freedom to Invent
$1B
Few Competitors

Lorem ipsum dolor sit Etiam aliquet eu mi quis Integer convallis suscipit
amet, consectetur lacinia. Ut fermentum a ante eu varius. Morbi a
adipiscing elit. magna ut eleifend. purus dolor.

Contoso
Pharmaceuticals

page 12
Competition Option 1

Contoso Pharmaceuticals Competitor

• Nulla a erat eget nunc hendrerit ultrices eu nec
nulla. Donec viverra leo aliquet, auctor quam id,
convallis orci.
• Sed in molestie est. Cras ornare turpis at ligula
posuere, sit amet accumsan neque lobortis.
• Maecenas mattis risus ligula, sed ullamcorper nunc
efficitur sed.
• Praesent venenatis quam tortor, id viverra nunc
rutrum a.
• Maecenas malesuada ultricies sapien sit amet
pharetra.
• Nunc tempus, risus sodales hendrerit, arcu dolor
commodo libero, a sollicitudin quam nulla quis
lectus. In at porta mauris.

Contoso
Pharmaceuticals

page 13
Competition Option 2
Convenience

Contoso
Pharmaceuticals

Expensive Affordable

Inconvenient Contoso
Pharmaceuticals

page 14
Growth Strategy
How will we scale in the future
Phase 1
Month, Year
• Lorem ipsum dolor sit
amet, consectetur
adipiscing elit.
• Etiam aliquet eu mi quis
lacinia. Ut fermentum a
magna ut eleifend.
Integer convallis suscipit
ante eu varius.
Phase 2 Phase 3
Month, Year Month, Year
• Morbi a purus dolor. • Donec viverra leo
Suspendisse sit amet aliquet, auctor quam id,
ipsum finibus justo convallis orci.
viverra blandit.
• Lorem ipsum dolor sit
• Ut congue quis tortor amet, consectetur
eget sodales. Nulla a erat adipiscing elit.
eget nunc hendrerit
ultrices eu nec nulla.
Contoso
Pharmaceuticals
page 15
Traction
Forecasting for success

Vendors Users Gross Company

Revenue Revenue Gross Revenue
$300,000

20YY 0 0 $0 $0
$250,000

20YY 10 100 $6,750 $1,013 $200,000

$150,000
20YY 50 500 $33,750 $5,063

$100,000
20YY 200 2000 $135,000 $20,250
$50,000

20YY 400 4000 $270,000 $40,500 $0

1 2 3 4 5 Contoso
Pharmaceuticals

page 16
Timeline
Our two-year action plan

Trials Marketing Launch

Month, 20YY Month, 20YY Month, 20YY

AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY

20YY 20YY

Legislation Investment Procurement

Month, 20YY Month, 20YY Month, 20YY

Contoso
Pharmaceuticals

page 17
Financials
Year 1 Year 2 Year 3
Detailers 5,000 40,000 160,000
Users 50,000 400,000 1 600,000
Sales 500,000 4 000,000 16 000,000
Average Price per Sale 75 80 90
Revenue @ 15% 5 625,000 48 000,000 216 000,000
• Cost of Revenue 0 0 0
Gross Profit 5 625,000 48 000,000 216 000,000
Expenses
• Sales & Marketing 5 062,500 38 400,000 151 200,000 70%
• Customer Service 1 687,500 9 600,000 21 600,000 10%

• Product
Development 562,500 2 400,000 10 800,000 5%
• Research 281,250 2 400,000 4 320,000 2%
Total Expenses 7 593,750 52 800,000 187 920,000
Contoso
EBIT -1 968,750 -4 800,000 28 080,000 13% Pharmaceuticals

page 18
Team

Mirjam Nils Victoria Lindqvist Angelica Astrom

COO COB CFO

Lorem ipsum dolor sit amet,
consectetur adipiscing elit. Etiam
aliquet eu mi quis lacinia. Ut
fermentum a magna ut eleifend.
Integer convallis suscipit ante eu
varius.
Morbi a purus dolor. Suspendisse sit
amet ipsum finibus justo viverra
blandit. Ut congue quis tortor eget
sodales. Nulla a erat eget nunc
hendrerit ultrices eu nec nulla.
Donec viverra leo aliquet, auctor quam
id, convallis orci. Sed in molestie est.
Cras ornare turpis at ligula posuere, sit
amet accumsan neque lobortis.

Contoso
Pharmaceuticals

page 19
Team Alternate

Mirjam Victoria Alexander

Nilsson Lindqvist Martensson
COO COB CFO

Angelica Mira Flora

Astrom Karlsson Berggren
Head of Operations Head of Technical Creative Director

Contoso
Pharmaceuticals

page 20
Funding

Fund Category Fund Category

Etiam aliquet eu mi quis lacinia.
Lorem ipsum dolor sit amet,
Ut fermentum a magna ut.
consectetur adipiscing elit.
$12,000
$14,000

$32,000

$82,000

Fund Category Fund Category

. Integer convallis suscipit ante eu Suspendisse sit amet ipsum finibus
varius. Morbi a purus dolor. justo viverra blandit. Ut congue quis
tortor eget sodales. Contoso
Pharmaceuticals

page 21
• Lorem ipsum dolor sit amet, consectetur
adipiscing elit. Etiam aliquet eu mi quis
lacinia. Summary
• Ut fermentum a magna ut eleifend. Integer
convallis suscipit ante eu varius. Morbi a Summary tagline or
purus dolor. Suspendisse sit amet ipsum sub-headline
finibus justo viverra blandit.
• Ut congue quis tortor eget sodales. Nulla a
erat eget nunc hendrerit ultrices eu. Contoso
Pharmaceuticals

page 22
Customize this Template

Template Editing
Instructions and Feedback

Contoso
Pharmaceuticals

page 23